Exploring Andrographis Paniculata in Long-Haul COVID Management: Additional Research on Nutraceuticals and Botanicals

Written By Hiroshi Wald


Exploring Andrographis Paniculata in Long-Haul COVID Management

  • Andrographis Paniculata in Focus:

    • Renowned for anti-inflammatory and antiviral properties.

    • Shows effectiveness against various influenza strains, indicating potential against SARS-CoV-2.

    • Enhances immune response, crucial in combating long-haul COVID symptoms.

  • Optimal Usage and Dosage:

    • Recommended intake: 100-600 mg daily of standardized extract.

    • Efficacy with minimal risk, suitable for long-term use.

  • Complementary Nutraceuticals and Botanicals:

    • A range of agents offering antiviral and immune enhancement benefits.

    • Continued research highlights their potential in holistic COVID-19 treatment.

  • Functional Medicine Perspective:

    • Emphasizes a holistic strategy integrating natural agents.

    • Focuses on scientific evidence for practical application.

Incorporating Andrographis Paniculata as part of a treatment regime for long-haul COVID offers a promising, natural approach. Its robust anti-inflammatory and antiviral properties, coupled with its ability to boost the immune system, make it a key component in managing the prolonged effects of COVID-19. As research progresses, the significance of Andrographis in functional medicine continues to grow, providing new insights and hope for those affected by long-haul COVID.

Source: https://www.ifm.org/news-insights/functional-medicine-approach-covid-19-additional-research-nutraceuticals-botanicals/

Hiroshi Wald
Previous

How to Treat Long-Haul COVID
Next

Andrographis Paniculata: A Potential Shield Against Pneumonia in Early COVID-19